Drug Discovery Market - Business Segmentation by
Revenue, Market Landscape, Present Scenario and Growth
Prospects 2026
Advancements in the field of biotechnology and pharmaceuticals, in order to identify active
ingredients in the form of drugs through drug discovery process, is gradually gaining pace in
the market. This drug discovery process involves screening of chemical libraries, identification
of the active ingredients for a natural remedy or by serendipitous discovery. Emergence of new
diseases, which include viral or infectious diseases leads to high demand for drug discovery for
these conditions. However, development of drugs is complex, costly, and risky process.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1631
The objective of drug discovery is to recognize the investigational drug success rates by stages,
pre-clinical studies, investigational new drug application-Phase I, Phase II, Phase III studies,
new drug application, and phase IV studies. The success during drug discovery process is very
low, as according to data published by Journal Research & Review 2016. According to the data,
it was estimated that among 5,000-10,000 drug discovery screening, only 250 enter the
preclinical testing and 5 enter the clinical testing and only 1 drug is approved by the regulatory
body, which takes roughly 5-10 years.
Furthermore, according to the same source, drug discovery process takes around 5-10 years for
the complete drug discovery, development, and introduction in the market, which costs around
US$1.7 Bn for complete process to undergo successfully.
Drug Discovery Market Dynamics:
A patent cliff provides an opportunity for manufactures to collaborate and participate in current
drug discovery model to sustain in the market. Manufacturers such as, Eli Lilly, Pfizer, Takeda,
Bristol-Myers Squibb and Gilead lost their patent in 2017, with some of their respective big
sellers that cover a range of indications such as multiple sclerosis, HIV, erectile dysfunction,
and cancer. Such patent loss forces companies to introduce innovative products to retain their
revenues and increase their revenue. After patent expiration, generic manufacturers enter the